^Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellström-Lindberg E, Tefferi A, Bloomfield CD. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. July 2009, 114 (5): 937–951. PMID 19357394. S2CID 3101472. doi:10.1182/blood-2009-03-209262.
^SEER Cancer Statistics Review, 1975–2006. Surveillance Epidemiology and End Results (SEER). Bethesda, MD: National Cancer Institute. [3 November 2009]. Table 1.4: Age-Adjusted SEER Incidence and U.S. Death Rates and 5-Year Relative Survival Rates By Primary Cancer Site, Sex and Time Period
^Jose RJ, Faiz SA, Dickey BF, Brown JS. Non-infectious respiratory disease in non-HIV immunocompromised patients. British Journal of Hospital Medicine (London, England). December 2014, 75 (12): 691–7. PMID 25488532. doi:10.12968/hmed.2014.75.12.691.
^Jose RJ, Dickey BF, Brown JS. Infectious respiratory disease in non-HIV immunocompromised patients. British Journal of Hospital Medicine (London, England). December 2014, 75 (12): 685–90. PMID 25488531. doi:10.12968/hmed.2014.75.12.685.